Anti-Cancer Injections & Vial

Reditux 100 mg is the trade name of a biosimilar version of rituximab, an anti-CD20 antibody used in the treatment of certain lymphomas, leukaemias and rheumatoid arthritis. Reditux is produced by Dr. Reddy's Laboratories, India's largest pharmaceutical company.

Other Information

• Minimum Order Quantity: 1 Piece/Pieces
• Port of Dispatch: Mumbai
• Production Capacity: 5000-6000
• Delivery Time: 7-8 days
• Packaging Details: High quality packaging and storage facilities are used to store products.

Daclizumab (trade name Zenapax) 25MG 5 ML is a therapeutic humanized monoclonal antibody to the alpha subunit of the IL-2 receptor of T cells. It is used to prevent rejection in organ transplantation, especially in kidney transplants.Daclizumab is currently in phase II clinical trials in the U.S.In April 2008, Hoffmann-La Roche, the pharmeceutical company that markets Daclizumab (under the name "Zenapax") in Europe, submitted an application to have its marketing authorisation withdrawn in the EU for commercial reasons. The drug faced diminishing market demand, according to the company. There were no safety concerns with its use.

Other Information

• Minimum Order Quantity: 1
• Port of Dispatch: Mumbai
• Production Capacity: 5000-6000
• Delivery Time: 7-8 days
• Packaging Details: We at 3S Corporation use high quality packaging material and possess modern storage facilities for storing the medicinal products

ALIMTA^® (pemetrexed for injection) is approved by the FDA in combination with cisplatin (another chemotherapy drug) for the initial treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA is not indicated for patients who have different type of NSCLC called squamous cell.

To Maintain the Effect of Initial Chemotherapy Before Worsening of Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer

ALIMTA is approved by the FDA for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy and whose disease has not worsened. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

If Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer Returns

ALIMTA is approved by the FDA as a single agent (used alone) for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, after prior chemotherapy. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

Treatment for Malignant Pleural Mesothelioma

ALIMTA is a treatment for malignant pleural mesothelioma (MPM), which is a cancer that affects the inside lining of the chest cavity. ALIMTA is given with cisplatin, another anticancer medicine (chemotherapy), when surgery is not an option.

Other Information

• Minimum Order Quantity: 1 Piece/Pieces
• Port of Dispatch: Mumbai
• Production Capacity: 5000-6000
• Delivery Time: 7-8 days

Avastin (bevacizumab) 100 MG 4 ML is a cancer medicine that interferes with the growth of cancer cells and slows their growth and spread in the body.

Avastin is used to treat a certain type of brain tumor, and certain types of cancers of the breast, kidney, lung, colon and rectum. It is usually given as part of a combination of cancer medicines.

Avastin may also be used for purposes not listed in this medication guide.

We 3S Corporation, are bulk supplier for Avastin  100 MG Vial

Other Information

• Minimum Order Quantity: 1
• Port of Dispatch: Mumbai

Carboplatin is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body. Carboplatin is used together with other cancer medications to treat ovarian cancer. Carboplatin may also be used for other purposes not listed in this medication guide.

3S Corporation India is a bulk drug supplier for Carboplatin 

Other Information

• Port of Dispatch: Mumbai
• Production Capacity: 1000
• Delivery Time: 5-6 days

Cisplatin is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body.

Cisplatin is used together with other medications to treat bladder cancer, testicular cancer, or ovarian cancer.

Cisplatin may also be used for purposes not listed in this medication guide.

3S Corporation is a bulk drug supplier for Cisplatin 50 Mg 50 Ml

Other Information

• Minimum Order Quantity: 1
• Port of Dispatch: Mumbai
• Production Capacity: 1000
• Delivery Time: 4-5 days

Doxorubicin is a cancer (antineoplastic) medication. Doxorubicin interferes with the growth of cancer cells and slows their growth and spread in the body.

Doxorubicin is used to treat many types of cancer.

Doxorubicin may also be used for purposes other than those listed in this medication guide.

3S Corporation is a bulk drug supplier for Doxorubicin 10 Mg & 50 Mg

Other Information

• Minimum Order Quantity: 1
• Port of Dispatch: Mumbai
• Production Capacity: 1000
• Delivery Time: 4-5 days

Erbitux is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body.

Erbitux is used to treat cancers of the colon and rectum. It is also used to treat head and neck cancer. It may be used alone or along with radiation treatments or other medicines.

Erbitux may also be used for other purposes not listed here.

3S Corporation is a bulk drug supplier for Erbitux 100 Mg 20 Ml. 

Other Information

• Minimum Order Quantity: 1
• Port of Dispatch: Mumbai
• Production Capacity: 1000
• Delivery Time: 4-5 days

Herceptin is a cancer medication (monoclonal antibody). It interferes with the growth of cancer cells and slows their growth and spread in your body.

Herceptin is used to treat metastatic breast cancer that has progressed after treatment with other chemotherapy. It may be used along with other medicines. Herceptin is also used to treat metastatic stomach cancer in combination with other chemotherapeutic agents.

Herceptin may also be used for other purposes not listed in this medication guide.

3S Corporation is a bulk drug supplier for Herceptin 440 Mg Vial 

Other Information

• Minimum Order Quantity: 1
• Port of Dispatch: Mumbai
• Production Capacity: 1000
• Delivery Time: 4-5 days

Ixempra (ixabepilone) is used to treat advanced breast cancer.

Ixempra is usually given after other cancer medications have been tried without successful treatment.

Ixempra may also be used for purposes not listed in this medication guide.

3S Corporation is a bulk drug supplier for Ixempra 15 Mg 

Other Information

• Minimum Order Quantity: 1
• Port of Dispatch: Mumbai
• Production Capacity: 1000
• Delivery Time: 4-5 days

Zoledronic acid (INN) or zoledronate (marketed by Novartis under the trade names Zometa, Zomera, Aclasta and Reclast) is a bisphosphonate. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis.[1] It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases.

An annual dose of zoledronic acid may also prevent recurring fractures in patients with a previous hip fracture.[2]

Reclast is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the U.S. Food and Drug Administration (FDA) also approved Reclast for the treatment of postmenopausal osteoporosis.

Chemocare.com uses generic names in all descriptions of drugs. Adrucil is the trade name for Fluorouracil. 5-fluorouracil and 5-FU are other names for Fluorouracil. In some cases, health care professionals may use the trade name Adrucil or other names 5-fluorouracil and 5-FU when referring to the generic drug name Fluorouracil.

Drug type:  5-fluorouracil is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug.  5-fluorouracil is classified as an "antimetabolite."  (For more detail, see "How this drug works" section below).

What this drug is used for:

• Colon and rectal cancer.
• Breast cancer.
• Gastrointestinal cancers including: anal, esphageal, pancreas and gastric (stomach).
• Head and neck cancer
  * Hepatoma (liver cancer).
• Ovarian cancer.
• Topical use (cream or solution) in basal cell cancer of the skin and actinic keratoses.-see document fluorouracil(cream).

Drug Type:

Paclitaxel is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Paclitaxel is classified as a "plant alkaloid," a "taxane" and an "antimicrotubule agent."  (For more detail, see "How Paclitaxel Works" section below).

What Paclitaxel Is Used For:

• Paclitaxel is used for the treatment of breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumor cancers. It has also been used in Kaposi's sarcoma.

Note:  If a drug has been approved for one use, physicians sometimes elect to use this same drug for other problems if they believe it might be helpful.

How Paclitaxel Is Given:

• Paclitaxel is given as an injection or infusion into the vein (intravenous, IV). 
• Paclitaxel is an irritant.  An irritant is a chemical that can cause inflammation of the vein through which it is given.  If the medication escapes from the vein it can cause tissue damage.  The nurse or doctor who gives Paclitaxel must be carefully trained.  If you experience pain or notice redness or swelling at the IV site while you are receiving Paclitaxel, alert your health care professional immediately. 
• Because severe allergic reactions have occurred in some people taking Paclitaxel, you will be asked to take medications to help prevent a reaction.  Your doctor will prescribe the exact regimen.
• Paclitaxel is given over various amounts of times and in various schedules. 
• There is no pill form of Paclitaxel.
• The amount of Paclitaxel and the schedule that it is given will receive depend on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated.  Your doctor will determine your dose and schedule.

Side Effects of Paclitaxel:

Important things to remember about the side effects of Paclitaxel include:

• Most people do not experience all of the side effects listed.
• Side effects are often predictable in terms of their onset and duration.
• Side effects are almost always reversible and will go away after treatment is complete.
• There are many options to help minimize or prevent side effects.
• There is no relationship between the presence or severity of side effects and the effectiveness of the medication.
• The side effects of Paclitaxel and their severity vary depending on how much of the drug is given, and/or the schedule in which it is given.p

Doxorubicin is an anti-cancer chemotherapy drug and is classified as an anthracycline antiobiotic. Doxorubicin is used to treat many cancers including bladder, breast, head and neck, leukemia (some types), liver, lung, lymphomas, mesothelioma, multiple myeloma, neuroblastoma, ovary, pancreas, prostate,

Pemetrexed is an anti-cancer chemotherapy drug. Alimta is the trade name for the generic drug name Pemetrexed. Premetrexed is used in the treatment of malignant mesothelioma, as well as the treatment of non-small cell lung cancer after prior chemotherapy.

Bleomycin is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug and is classified as an antitumor antibiotic. Bleomycin is used in the treatment of squamous cell cancers, melanoma, sarcoma, testicular cancer, Hodgkin's and non-Hodgkin's lymphoma, and pleural effusion. Bleomycin and Blenoxane - Chemotherapy

VELCADE® (bortezomib) for Injection is an antineoplastic agent available for intravenous injection or subcutaneous use. Each single use vial contains 3.5 mg of bortezomib as a sterile lyophilized powder. Inactive ingredient: 35 mg mannitol, USP.

Bortezomib is a modified dipeptidyl boronic acid. The product is provided as a mannitol boronic ester which, in reconstituted form, consists of the mannitol ester in equilibrium with its hydrolysis product, the monomeric boronic acid. The drug substance exists in its cyclic anhydride form as a trimeric boroxine.

The chemical name for bortezomib, the monomeric boronic acid, is [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl) amino]propyl]amino]butyl] boronic acid.

VELCADE ® (bortezomib) for Injection is an antineoplastic agent available for intravenous injection or subcutaneous use. Each single use vial contains 3.5 mg of bortezomib as a sterile lyophilized powder. Inactive ingredient: 35 mg mannitol, USP.

Bortezomib is a modified dipeptidyl boronic acid. The product is provided as a mannitol boronic ester which, in reconstituted form, consists of the mannitol ester in equilibrium with its hydrolysis product, the monomeric boronic acid. The drug substance exists in its cyclic anhydride form as a trimeric boroxine.

Liposomal Doxorubicin:Doxorubicin (liposomal) is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. It is the drug doxorubicin encapsulated in a closed lipid sphere (liposome). This medication is classified as an anthracycline antibiotic.Liposomal doxorubicin is a chemotherapy drug usually given to treat advanced ovarian cancer, advanced breast cancer and Aids-related Kaposi's sarcoma. It may also be given to treat myeloma.

Irinotecan is used alone or in combination with other medications to treat colon or rectal cancer (cancer that begins in the large intestine). Irinotecan is in a class of antineoplastic medications called topoisomerase I inhibitors. It works by stopping the growth of cancer cells.Irinotecan comes as a liquid to be given over 90 minutes intravenously (into a vein) by a doctor or nurse. It is usually given not more often than once a week, according to a schedule that alternates one or more weeks when you receive irinotecan with one or more weeks when you do not receive the medication. Your doctor will choose the schedule that will work best for you.

Topotecan is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. This medication is classified as an topoisomerase 1 inhibitor. Hycamtin.

Topotecan may be given as a drip (infusion) in one of the following ways:

• by injection into a vein (intravenously), through a fine tube inserted into a vein, usually in the back of your hand (cannula)
• through a fine, plastic tube inserted under the skin and into a vein near your collarbone (central line)
• into a fine tube inserted into a vein in the crook of your arm (PICC line).

The infusion takes approximately 30 minutes. Topotecan can also be taken as capsules that should be swallowed whole with a glass of water. The capsules can be taken with or without food. Your doctor may want you to take a combination of 0.25mg and 1mg capsules. You need to make sure you're taking the right dose and that you don't take too much or too little.

Capecitabine is an anti-cancer chemotherapy drug classified as an antimetabolite. Capecitabine is used to treat metastatic colon or rectal cancer and metastatic breast cancer. Capecitabine and Xeloda.
How it is given Back to top

Your doctor may want you to take a combination of 500mg and 150mg tablets. You need to make sure that you're taking the right dose and that you don't take too much or too little.

The tablets should be swallowed whole with a glass of water. They should be taken within half an hour of finishing a meal as capecitabine works best if it's broken down in the stomach with food. You should take them in the morning just after breakfast, and then again just after your evening meal, so that the doses are spaced at least eight hours apart or, if possible, 10–12 hours apart.

If you have trouble swallowing capecitabine tablets, they can be dissolved in a 200ml glass of warm water. The mixture should be stirred with a spoon until the tablets are completely dissolved, and then drunk immediately. You can add some blackcurrant juice just before swallowing to help disguise the taste. The glass and spoon should be washed and kept separate from your other crockery and cooking utensils.

carboplatin [kahr″bo-plat´in]
a platinum coordination compound that interferes with functioning of cellular DNA; used as an antineoplastic agent to treat cancers of the ovary, lung, head and neck, testes, bladder, brain, and other organs.

Bicalutamide is a hormone therapy. It is classified as an anti-androgen. Often given in combination with LHRH agonist, another type of hormone therapy. Casodex. Drug class and mechanism: bicalutamide is an oral medication that is used for treating cancer of the prostate. It belongs to a class of drugs called anti-androgens which includes flutamide (eulexin) and nilutamide (nilandron). Androgens (an example of which is testosterone) are hormones that are produced and released by the adrenal glands. They are responsible for supporting (stimulating) tissues that primarily are thought of as male, for example, the male prostate gland. Male traits that also are influenced by androgens include facial and body hair and small breasts. Anti-androgens prevent the action of androgens by blocking the receptors for androgens on the cells of tissues, for example, the cells of the prostate gland. In addition to normal prostate cells, androgens also have been shown to stimulate the growth of cancer cells within the prostate. Bicalutamide is thought to prevent the growth of prostate cancer by blocking the effects of androgens on the cancer cells

Carboplatin is an anticancer drug chemotherapy drug and is classified as an alkylating agent. Carboplatin is used to treat ovarian cancer and other types of cancer including lung, head and neck, endometrial, esophageal, bladder, breast, and cervical.

• Carboplatin is usually given by infusion into a vein (intravenous, IV).
• Carboplatin can also be given intra-peritoneal, directly into the peritoneal cavity in the abdomen. 
• The amount of Carboplatin you receive depends on many factors, including your height and weight, your general health or other health problems, and how your body responds to it.  Your doctor will determine your dose and schedule. 

Oxaliplatin is an anti-cancer chemotherapy drug and is classified as an alkylating agent. Oxaliplatin is used to treat colon or rectal cancer that has spread (metastasized) and it is often given in combination with other anticancer drugs such as Fluorouracil and Leucovorin.

• It is given by infusion into the vein (intravenous, IV).
• There is no pill form of Oxaliplatin.
• The amount of Oxaliplatin you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer you have. Your doctor will determine your dosage and schedule.

Letrozole is a hormone therapy and is classified as an aromatase inhibitor. Letrozole is used to treat estrogen receptor positive or hormone receptor unknown locally advanced or metastatic (spread) breast cancer in post-menopausal women. Letrozole is also used to treat advanced breast cancer in post-menopausal women. It works by decreasing the amount of estrogen produced by the body. This can slow or stop the growth of some types of breast cancer cells that need estrogen to grow.

Letrozole comes as a tablet to take by mouth once a day with or without food. Take letrozole at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take letrozole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

You may need to take letrozole for several years or longer. Continue to take letrozole even if you feel well. Do not stop taking letrozole without talking to your doctor.

Chlorambucil is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. This medication is classified as an alkylating agent. Leukeran.Chlorambucil is used treat a certain type of chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells). Chlorambucil is also used to treat non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (types of cancer that begin in certain white blood cells that normally fight infection). Chlorambucil is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.

Chlorambucil can cause a decrease in the number of blood cells in your bone marrow. Your doctor will order laboratory tests before, during, and after your treatment to see if your blood cells are affected by this drug. Keep all appointments with the laboratory.

Chlorambucil may increase the risk that you will develop other cancers. Talk to your doctor about this risk.

Chlorambucil may interfere with the normal menstrual cycle (period) in women and may stop sperm production in men. Chlorambucil may cause permanent infertility (difficulty becoming pregnant); however, you should not assume that you cannot get pregnant, or that you cannot get someone else pregnant. Women who are pregnant should tell their doctors before they begin taking this drug. You should not plan to have children while receiving chemotherapy or for a while after treatments. (Talk to your doctor for further details.) Use a reliable method of birth control to prevent pregnancy. If you become pregnant while taking chlorambucil, call your doctor immediately. Chlorambucil may harm the fetus.

Genetic Medicine for Taxotere. It is used as an anti-cancer medicine. We at 3S Corporation possess generic brands for docetaxel which are 100% genuine manufactured by  known Indian pharmaceutical companies like CIPLA, DABUR etc. 

Cyclophosphamide is used alone or in combination with other medications to treat Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (types of cancer that begin in a type of white blood cells that normally fights infection); cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune system that first appear as skin rashes); multiple myeloma (a type of cancer of the bone marrow); and certain types of leukemia (cancer of the white blood cells), including chronic lymphocytic leukemia (CLL), chronic myelogenous leukemia (CML), acute myeloid leukemia (AML, ANLL), and acute lymphoblastic leukemia (ALL). It is also used to treat retinoblastoma (cancer in the eye), neuroblastoma (a cancer that begins in nerve cells and occurs mainly in children), ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed), and breast cancer. Cyclophosphamide is also used to treat nephrotic syndrome (a disease that is caused by damage to the kidneys) in children whose disease has not improved, has gotten worse, or has come back after taking other medications or in children who experienced intolerable side effects with other medications. Cyclophosphamide is in a class of medications called alkylating agents. When cyclophosphamide is used to treat cancer, it works by slowing or stopping the growth of cancer cells in your body. When cyclophosphamide is used to treat nephrotic syndrome, it works by suppressing your body's immune system.
Cyclophosphamide is used alone or in combination with other medications to treat Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (types of cancer that begin in a type of white blood cells that normally fights infection); cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune system that first appear as skin rashes); multiple myeloma (a type of cancer of the bone marrow); and certain types of leukemia (cancer of the white blood cells), including chronic lymphocytic leukemia (CLL), chronic myelogenous leukemia (CML), acute myeloid leukemia (AML, ANLL), and acute lymphoblastic leukemia (ALL). It is also used to treat retinoblastoma (cancer in the eye), neuroblastoma (a cancer that begins in nerve cells and occurs mainly in children), ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed), and breast cancer. Cyclophosphamide is also used to treat nephrotic syndrome (a disease that is caused by damage to the kidneys) in children whose disease has not improved, has gotten worse, or has come back after taking other medications or in children who experienced intolerable side effects with other medications. Cyclophosphamide is in a class of medications called alkylating agents. When cyclophosphamide is used to treat cancer, it works by slowing or stopping the growth of cancer cells in your body. When cyclophosphamide is used to treat nephrotic syndrome, it works by suppressing your body's immune system.

Melphalan is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. This medication is classified as an alkylating agent. Alkeran, L-PAM, L-Sarcolysin, Phenylalanine MustardMelphalan is a chemotherapy drug that is usually given to treat multiple myeloma. It's occassionally used to treat melanoma and ovarian cancer

Nausea, Vomiting - Cancer Symptoms, Chemotherapy & Chemo Side Effects
Nausea & Chemotherapy Nausea - Vomiting from cancer drugs. Unfortunately, certain chemotherapy drugs can cause nausea and vomiting. Luckily, there are many drugs and medications that your doctor can prescribe to prevent, lessen, or relieve the nausea and vomiting associated with chemotherapy - Emend, Ondansetron, Kytri.

Daunorubicin (liposomal) is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. It is the drug daunorubicin encapsulated in a closed lipid sphere (liposome). This medication is classified as an anthracyline antitumor antibiotic. DaunoXome.

Anastrozole is used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause (change of life; end of monthly menstrual periods). This medication is also used in women, who have experienced menopause, as a first treatment of breast cancer that has spread within the breast or to other areas of the body. This medication is also used to treat breast cancer in women whose breast cancer has worsened after taking tamoxifen (Nolvadex). Anastrozole is in a class of medications called nonsteroidal aromatase inhibitors. It works by decreasing the amount of estrogen the body makes. This can slow or stop the growth of many types of breast cancer cells that need estrogen to grow.

How should this medicine be used?

Anastrozole comes as a tablet to take by mouth. It is usually taken once a day with or without food. Take anastrozole at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take anastrozole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

You may need to take anastrozole for several years or longer. Continue to take anastrozole even if you feel well. Do not stop taking anastrozole without talking to your doctor.

 

Exemestane is a hormone therapy and is classified as an aromatase inhibitor. Exemestane is used to treat advanced breast cancer in post-menopausal women whose disease has progressed following tamoxifen therapy. Exemestane and Aromasin - Chemotherapy Drugs & Side Effect.

Bevacizumab is the generic name for the trade name chemotherapy drug Avastin. Bevacizumab is classified as a monoclonal antibody and anti-angiogenesis drug and is used for treatment of metastatic colon or rectal cancer, used as part of a combination chemotherapy regimen. Bevacizumab and Avastin - Chemotherapy Drugs.

Targeted therapy in the treatment of cancer has significantly improved the clinical benefits over conventional therapy in indications like head and neck, colorectal etc. Molecular targets such as epidermal growth factor (EGFR) have been well established in the treatment of various solid tumors. Screening for the molecular target and treating the patient with the respective targeted therapeutic agents with or without combination therapy had changed the treatment modalities in recent past. Nimotuzumab is a humanized monoclonal antibody binds to the extracellular domain of EGFR, and consequently inhibits tyrosine kinase activation. Nimotuzumab is the only-affinity optimized™ anti-EGFR monoclonal antibody exhibits superior safety profile among the class of anti-EGFR agents. Anti-tumor efficacy of nimotuzumab was well correlated with the level EGFR expression in tumors in vitro/ in vivo

Bleomycin is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug and is classified as an antitumor antibiotic. Bleomycin is used in the treatment of squamous cell cancers, melanoma, sarcoma, testicular cancer, Hodgkin's and non-Hodgkin's lymphoma, and pleural effusion. Bleomycin and Blenoxane - Chemotherapy.

Letrozole is a hormone therapy and is classified as an aromatase inhibitor. Letrozole is used to treat estrogen receptor positive or hormone receptor unknown locally advanced or metastatic (spread) breast cancer in post-menopausal women. Letrozole is also used to treat advanced breast cancer in post-menopausal women.

Letrozole is used treat early breast cancer in women who have experienced menopause (change of life; end of monthly menstrual periods) and who have had other treatments, such as radiation or surgery to remove the tumor. It is also used to treat early breast cancer in women who have experienced menopause and who have already been treated with a medication called tamoxifen (Nolvadex) for 5 years. Letrozole is also used in women who have experienced menopause as a first treatment of breast cancer that has spread within the breast or to other areas of the body or in women whose breast cancer has worsened while they were taking tamoxifen. Letrozole is in a class of medications called non steroidal aromatase inhibitors. It works by decreasing the amount of estrogen produced by the body. This can slow or stop the growth of some types of breast cancer cells that need estrogen to grow.

How should this medicine be used?

Letrozole comes as a tablet to take by mouth once a day with or without food. Take letrozole at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take letrozole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

You may need to take letrozole for several years or longer. Continue to take letrozole even if you feel well. Do not stop taking letrozole without talking to your doctor.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

Chlorambucil is used treat a certain type of chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells). Chlorambucil is also used to treat non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (types of cancer that begin in certain white blood cells that normally fight infection). Chlorambucil is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.

How should this medicine be used?

Chlorambucil comes as a tablet to take by mouth. It is usually taken once a day for 3 to 6 weeks, but sometimes may be taken intermittently, as a single dose once every 2 weeks, or as a single dose once a month. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have. Take chlorambucil at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take chlorambucil exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor may adjust your dose of chlorambucil depending on your response to treatment and any side effects that you experience. Talk to your doctor about how you are feeling during your treatment. Do not stop taking chlorambucil without talking to your doctor.

IMPORTANT WARNING:

Chlorambucil can cause a decrease in the number of blood cells in your bone marrow. Your doctor will order laboratory tests before, during, and after your treatment to see if your blood cells are affected by this drug. Keep all appointments with the laboratory.

Chlorambucil may increase the risk that you will develop other cancers. Talk to your doctor about this risk.

Chlorambucil may interfere with the normal menstrual cycle (period) in women and may stop sperm production in men. Chlorambucil may cause permanent infertility (difficulty becoming pregnant); however, you should not assume that you cannot get pregnant, or that you cannot get someone else pregnant. Women who are pregnant should tell their doctors before they begin taking this drug. You should not plan to have children while receiving chemotherapy or for a while after treatments. (Talk to your doctor for further details.) Use a reliable method of birth control to prevent pregnancy. If you become pregnant while taking chlorambucil, call your doctor immediately. Chlorambucil may harm the fetus.

Paclitaxel is an anti-cancer chemotherapy drug classified as a plant alkaloid, a taxane and an antimicrotubule agent. Paclitaxel is used for the treatment of breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumor cancers. It has also been used in Kaposi's sarcoma. Paclitax

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; feeling like you might pass out; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these serious side effects:

• Slow heart rate;
• Seizure (black-out or convulsions);
• Pale skin, easy bruising or bleeding, unusual weakness;
• Fever, chills, body aches, flu symptoms;
• White patches or sores inside your mouth or on your lips;

What are the precautions when taking paclitaxel (Taxol)?

Before using paclitaxel, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients (such as polyoxyethylated castor oil), which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: a very low white blood cell count.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: blood disorders, decreased bone marrow function, current infections, heart problems (e.g., fast/slow/irregular heartbeat), high or low blood pressure, liver disease.

Docetaxel is approved to be used alone or with other drugs to treat:

    Breast cancer that is locally advanced or has metastasized (spread to other parts of the body) and has not gotten better with other chemotherapy. It is also used to treat breast cancer that is node-positive and can be removed by surgery.

    Gastric (stomach) cancer that is advanced. It is used in patients who have not been treated with chemotherapy for advanced disease.

    Non-small cell lung cancer in certain patients whose cancer is locally advanced or has metastasized.

    Prostate cancer that has metastasized in men whose cancer is hormone-refractory (does not respond to hormone treatment).

    Squamous cell carcinoma of the head and neck that is locally advanced.

Docetaxel is also being studied in the treatment of other types of cancer.

Gemcitabine is an anti-cancer chemotherapy drug and is classified as an antimetabolite. Gemcitabine is used to treat pancreas cancer, non-small cell lung cancer, bladder cancer, soft-tissue sarcoma, and metastatic breast cancer.Gemcitabine is given as an injection in a vein over a period of 30 minutes. Pancreatic cancer patients are given gemcitabine once a week for up to 7 weeks to start, then a week without treatment. After that, the dose is once a week for 3 weeks followed by a week off. When given for breast or ovarian cancer, it's usually once a week for 2 weeks, then 1 week off. For lung cancer or other cancer patients, it usually is given weekly for 3 weeks with 1 week off. The dose depends on your size, your blood counts, how well you did on the last cycle of treatment, and the cancer being treated.

This drug can lower your white blood cell count, especially in the weeks after the drug is given. This can increase your chance of getting an infection. Be sure to let your doctor or nurse know right away if you have any signs of infection, such as fever (100.5° or higher), chills, pain when passing urine, a new cough, or bringing up sputum.

This drug may lower your platelet count in the weeks after it is given, which can increase your risk of bleeding. Speak with your doctor before taking any drugs or supplements that might affect your body's ability to stop bleeding, such as aspirin or aspirin-containing medicines, warfarin (Coumadin), or vitamin E. Tell your doctor right away if you have unusual bruising, or bleeding such as nosebleeds, bleeding gums when you brush your teeth, or black, tarry stools.

This drug may lower your red blood cell count. If this occurs, it is usually a few weeks after starting treatment. A low red blood cell count (known as anemia) can cause shortness of breath, or make you to feel weak or tired all the time. Your doctor may give you medicines to help prevent or treat this condition, or you may need to get blood transfusions.

Do not get any immunizations (vaccines), either during or after treatment with this drug, without your doctor's OK. Gemcitabine may affect your immune system. This could make vaccinations ineffective, or could even lead to serious infections if you get a live virus vaccine during or soon after treatment. Try to avoid contact with people who have recently received a live virus vaccine, such as the oral polio vaccine or smallpox vaccine. Check with your doctor about this.

Avoid pregnancy during and for at least a few months after treatment, since exposure to this drug may harm the fetus. Talk with your doctor about this.

Cisplatin is approved to be used alone or with other drugs to treat:

    Bladder cancer that cannot be treated with surgery or radiation therapy.

    Cervical cancer that is advanced and cannot be treated with surgery or radiotherapy.

    Malignant mesothelioma that cannot be treated with surgery.

    Non-small cell lung cancer that is locally advanced, advanced, or has metastasized (has spread to other parts of the body) and cannot be treated with surgery.

    Ovarian cancer that is advanced or has metastasized in patients whose disease has not gotten better with other types of treatment or chemotherapy.

    Squamous cell carcinoma of the head and neck that is locally advanced and cannot be treated with surgery.

    Testicular cancer in patients who have already had surgery or radiotherapy.

Cisplatin is also being studied in the treatment of other types of cancer.

Chlorambucil is used treat a certain type of chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells). Chlorambucil is also used to treat non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (types of cancer that begin in certain white blood cells that normally fight infection). Chlorambucil is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.

How should this medicine be used?

Chlorambucil comes as a tablet to take by mouth. It is usually taken once a day for 3 to 6 weeks, but sometimes may be taken intermittently, as a single dose once every 2 weeks, or as a single dose once a month. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have. Take chlorambucil at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take chlorambucil exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Chlorambucil may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• nausea

• vomiting

• sores in the mouth and throat

• tiredness

• missed menstrual periods (in girls and women)

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

• skin rash

• unusual bruising or bleeding

• black, tarry stools

• red urine

• cough

• sore throat

• congestion

• fever

• difficulty breathing

• seizures

• yellowing of the skin or eyes

• pain in the upper right part of the stomach

• dark colored urine

• frequent urination

• unusual lumps or masses

Chlorambucil may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

Irinotecan is used alone or in combination with other medications to treat colon or rectal cancer (cancer that begins in the large intestine). Irinotecan is in a class of antineoplastic medications called topoisomerase I inhibitors. It works by stopping the growth of cancer cells.
Irinotecan comes as a liquid to be given over 90 minutes intravenously (into a vein) by a doctor or nurse. It is usually given not more often than once a week, according to a schedule that alternates one or more weeks when you receive irinotecan with one or more weeks when you do not receive the medication. Your doctor will choose the schedule that will work best for you.
Irinotecan may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• nausea

• vomiting

• constipation

• swelling and sores in the mouth

• heartburn

• loss of appetite

• weight loss

• hair loss

• weakness

• sleepiness

• pain, especially back pain

Bicalutamide is a hormone therapy. It is classified as an anti-androgen. Often given in combination with LHRH agonist, another type of hormone therapy.

Bicalutamide is used with another medication (luteinizing hormone-releasing hormone [LHRH]; such as leuprolide or goserelin) to treat metastatic prostate cancer (cancer that started in the prostate and has spread to other parts of the body). Bicalutamide is in a class of medications called nonsteroidal antiandrogens. It works by blocking the effect of androgen (a male hormone), to stop the growth and spread of cancer cells.

Bicalutamide comes as a tablet to take by mouth. It is usually taken with or without food once a day, either in the morning or evening. Take bicalutamide at around the same time every day. You should begin taking bicalutamide on the same day you begin injecting the luteinizing hormone-releasing hormone.
Bicalutamide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• hot flashes or flushing

• bone, back, or pelvic pain

• muscle weakness

• muscle or joint pain

• headache

• shortness of breath

• increased blood pressure

• swelling of the hands, feet, ankles, or lower legs

• cough

• constipation

• nausea

• vomiting

• abdominal pain

• diarrhea

• gas

• change in weight (loss or gain)

Cyclophosphamide is used alone or in combination with other medications to treat Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (types of cancer that begin in a type of white blood cells that normally fights infection); cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune system that first appear as skin rashes); multiple myeloma (a type of cancer of the bone marrow); and certain types of leukemia (cancer of the white blood cells), including chronic lymphocytic leukemia (CLL), chronic myelogenous leukemia (CML), acute myeloid leukemia (AML, ANLL), and acute lymphoblastic leukemia (ALL). It is also used to treat retinoblastoma (cancer in the eye), neuroblastoma (a cancer that begins in nerve cells and occurs mainly in children), ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed), and breast cancer. Cyclophosphamide is also used to treat nephrotic syndrome (a disease that is caused by damage to the kidneys) in children whose disease has not improved, has gotten worse, or has come back after taking other medications or in children who experienced intolerable side effects with other medications. Cyclophosphamide is in a class of medications called alkylating agents. When cyclophosphamide is used to treat cancer, it works by slowing or stopping the growth of cancer cells in your body. When cyclophosphamide is used to treat nephrotic syndrome, it works by suppressing your body's immune system.

How should this medicine be used?

Cyclophosphamide comes as a tablet to take by mouth once a day. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer or condition you have. Take cyclophosphamide at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take cyclophosphamide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Before taking cyclophosphamide,

• Tell your doctor and pharmacist if you are allergic to cyclophosphamide, other alkylating agents such as bendamustine (Treanda^®), busulfan (Myerlan^®, Busulfex^®), carmustine (BiCNU^®, Gliadel^® Wafer), chlorambucil (Leukeran^®), ifosfamide (Ifex^®), lomustine (CeeNU^®), melphalan (Alkeran^®), procarbazine (Mutalane^®), or temozolomide (Temodar^®), any other medications, or any of the ingredients in cyclophosphamide. Ask your pharmacist for a list of the ingredients.
• Tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: allopurinol (Zyloprim^®), cortisone acetate, doxorubicin (Adriamycin^®, Doxil^®), hydrocortisone (Cortef^®), or phenobarbital (Luminal^® Sodium). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with cyclophosphamide, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.
• Tell your doctor if you have previously received treatment with other chemotherapy medications or if you have had x-rays recently. Also tell your doctor if you have or have ever had kidney or liver disease.
• You should know that cyclophosphamide may interfere with the normal menstrual cycle (period) in women and may stop sperm production in men.

Cytarabine, or cytosine arabinoside, is a chemotherapy agent used mainly in the treatment of cancers of white blood cells such as acute myeloid leukemia (AML) and non-Hodgkin lymphoma.[1] It is also known as Ara-C (Arabinofuranosyl Cytidine).[2] It kills cancer cells by interfering with DNA synthesis.

It is called cytosine arabinoside because it combines a cytosine base with an arabinose sugar. Cytosine normally combines with a different sugar, deoxyribose, to form deoxycytidine, a component of DNA. Certain sponges, where it was originally found, use arabinoside sugars to form a different compound (not part of DNA). Cytosine arabinoside is similar enough to human cytosine deoxyribose (deoxycytidine) to be incorporated into human DNA, but different enough that it kills the cell. This mechanism is used to kill cancer cells. Cytarabine is the first of a series of cancer drugs that altered the sugar component of nucleosides. Other cancer drugs modify the base

Article Related Diseases

    Smaller
    Medium
    Larger

    1
    2
    3
    4
    Next

Disclaimer:
Cytarabine - injection, Cytosar-U, Tarabine PFS
Take the Chronic Fatigue Syndrome Quiz    
Take the Chronic Fatigue Quiz Take the Chronic Fatigue Quiz
Surprising Benefits of Sex Slideshow Surprising Benefits of Sex Slideshow
Foods & Drinks That Make You Gotta Go Slideshow Foods & Drinks That Make You Gotta Go Slideshow Pictures

GENERIC NAME: CYTARABINE - INJECTION (sye-TAIR-uh-bean)
BRAND NAME(S): Cytosar-U, Tarabine PFS

Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage

WARNING: This medication may cause serious (rarely fatal) blood disorders (bone marrow suppression leading to anemia, low number of white blood cells and platelets). Liver problems may also occur. Your doctor will monitor you closely for these side effects.

Tell your doctor immediately if you develop any signs of infection (e.g., fever, chills, persistent sore throat), unusual fatigue, easy bruising or bleeding, nausea, vomiting, diarrhea, stomach/abdominal pain, dark urine, yellowing eyes/skin, or mouth sores.

Gemcitabine is an anti-cancer chemotherapy drug and is classified as an antimetabolite. Gemcitabine is used to treat pancreas cancer, non-small cell lung cancer, bladder cancer, soft-tissue sarcoma, and metastatic breast cancer.

• GEMZAR is approved by the FDA in combination with carboplatin (another type of chemotherapy) for the patient with advanced ovarian cancer that has returned at least 6 months after the patient had finished platinum-based therapy.
• GEMZAR is approved by the FDA in combination with cisplatin (another type of chemotherapy) for the first-line treatment of patients (for whom surgery is not possible) with locally advanced (stage IIIA or stage IIIB) or metastatic (stage IV or cancer that has spread) non-small cell lung cancer.
• GEMZAR is approved by the FDA in combination with paclitaxel for the first-line treatment of patients with metastatic breast cancer after they have received another type of chemotherapy called an anthracycline, unless their medical condition did not allow them to receive an anthracycline.
• GEMZAR is approved by the FDA as a single agent (given alone) as the first-line treatment for patients with locally advanced (stage II or stage III when surgery is not an option) or metastatic (stage IV) adenocarcinoma of the pancreas. GEMZAR is also indicated for patients previously treated with 5-FU (another type of chemotherapy).

The most common side effects are low blood cell counts (red blood cells, white blood cells, and platelets); fever; infection; hair loss; tiredness; nausea; vomiting; constipation; diarrhea; rash; shortness of breath; muscle aches; blood in urine; hearing changes and numbness or tingling in your toes or fingers. Lab work may identify additional side effects.

Dactinomycin is used to treat Wilms and Ewings tumors, testicular cancer, sarcomas (cancers that grow from cartilage, fat, muscle, or bone), and other types of cancer.

Dactinomycin is used in combination with other medications, surgery, and/or radiation therapy to treat Wilms' tumor (a type of kidney cancer that occurs in children) and rhabdomyosarcoma (cancer that forms in muscles) in children. Dactinomycin is also used in combination with other medications to treat certain types of testicular cancer and Ewing's sarcoma (a type of cancer in bones or muscles). Dactinomycin is also used alone or in combination with other medications to treat gestational trophoblastic tumors (a type of tumor that forms inside a woman's uterus while she is pregnant). Dactinomycin may also be used to treat certain types of cancerous tumors that are located in a specific area of the body. Dactinomycin is a type of antibiotic that is only used in cancer chemotherapy. It works by slowing or stopping the growth of cancer cells in your body

Dactinomycin comes as a powder to be mixed with liquid to be injected intravenously (into a vein) by a doctor or nurse in a medical facility. The length of treatment depends on the type of cancer you have, the types of other drugs you are taking, and how well your body responds to treatment. Your doctor may need to stop or delay your treatment if you experience certain side effects. Dactinomycin may also be injected by a doctor directly into a specific the part of the body or the organ to treat the area where a tumor is located.

Daunorubicin is used with other chemotherapy drugs to treat a certain type of acute myeloid leukemia (AML; a type of cancer of the white blood cells). Daunorubicin is also used with other chemotherapy drugs to treat a certain type of acute lymphocytic leukemia (ALL; a type of cancer of the white blood cells). Daunorubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.

Daunorubicin comes as a solution (liquid) or as a powder to be mixed with liquid to be injected intravenously (into a vein) by a doctor or nurse in a medical facility along with other chemotherapy medications. When daunorubicin is used to treat AML, it is usually injected once a day on certain days of your treatment period. When daunorubicin is used to treat ALL, it is usually injected once a week. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.

IMPORTANT WARNING:

Daunorubicin injection must be given in a hospital or medical facility under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer.

Daunorubicin may cause serious or life-threatening heart problems at any time during your treatment or months to years after your treatment has ended. Your doctor will order tests before and during your treatment to see if your heart is working well enough for you to safely receive daunorubicin. These tests may include an electrocardiogram (ECG; test that records the electrical activity of the heart) and an echocardiogram (test that uses sound waves to measure your heart's ability to pump blood). Your doctor may tell you that you should not receive this medication if the tests show your heart's ability to pump blood has decreased. Tell your doctor if you have or have ever had any type of heart disease or radiation (x-ray) therapy to the chest area. Tell your doctor and pharmacist if you are taking or have ever received certain cancer chemotherapy medications such as doxorubicin (Doxil), epirubicin (Ellence), idarubicin (Idamycin), or mitoxantrone (Novantrone), cyclophosphamide (Cytoxan), or trastuzumab (Herceptin). If you experience any of the following symptoms, call your doctor immediately: shortness of breath; difficulty breathing; swelling of the hands, feet, ankles or lower legs; or fast, irregular, or pounding heartbeat.

Daunorubicin can cause a severe decrease in the number of blood cells in your bone marrow. This may cause certain symptoms and may increase the risk that you will develop a serious infection or bleeding. If you experience any of the following symptoms, call your doctor immediately: fever, sore throat, ongoing cough and congestion, or other signs of infection; unusual bleeding or bruising.

Doxorubicin is used in combination with other medications to treat certain types of bladder, breast, lung, stomach, and ovarian cancer; Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (cancer that begins in the cells of the immune system); and certain types of leukemia (cancer of the white blood cells), including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML, ANLL). Doxorubicin is also used alone and in combination with other medications to treat certain types of thyroid cancer and certain types of soft tissue or bone sarcomas (cancer that forms in muscles and bones). It is also used to treat neuroblastoma (a cancer that begins in nerve cells and occurs mainly in children) and Wilms' tumor (a type of kidney cancer that occurs in children). Doxorubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.

Doxorubicin comes as a solution (liquid) or as a powder to be mixed with liquid to be injected intravenously (into a vein) by a doctor or nurse in a medical facility. It is usually given once every 21–28 days. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.

Doxorubicin should be administered only into a vein. However, it may leak into surrounding tissue causing severe irritation or damage. Your doctor or nurse will monitor your administration site for this reaction. If you experience any of the following symptoms, call your doctor immediately: pain, itching, redness, swelling, blisters, or sores in the place where the medication was injected.

Doxorubicin may cause serious or life-threatening heart problems at any time during your treatment or months to years after your treatment has ended. Your doctor will order tests before and during your treatment to see if your heart is working well enough for you to safely receive doxorubicin. These tests may include an electrocardiogram (ECG; test that records the electrical activity of the heart) and an echocardiogram (test that uses sound waves to measure your heart's ability to pump blood). Your doctor may tell you that you should not receive this medication if you have an abnormal heart rate or if the tests show your heart's ability to pump blood has decreased. Tell your doctor if you have or have ever had any type of heart disease, a heart attack, or radiation (x-ray) therapy to the chest area. Tell your doctor and pharmacist if you are taking or have ever received certain cancer chemotherapy medications such as cyclophosphamide (Cytoxan), daunorubicin (Cerubidine, DaunoXome), epirubicin (Ellence), idarubicin (Idamycin), mitoxantrone (Novantrone), paclitaxel (Abraxane, Onxol), trastuzumab (Herceptin), or verapamil (Calan, Isoptin). If you experience any of the following symptoms, call your doctor immediately: shortness of breath; difficulty breathing; swelling of the hands, feet, ankles or lower legs; or fast, irregular, or pounding heartbeat.

Doxorubicin can cause a severe decrease in the number of blood cells in your bone marrow.

Cetuximab is used with or without radiation therapy to treat a certain type of cancer of the head and neck. Cetuximab is also used alone or in combination with another medication to treat a certain type of cancer of the colon (large intestine) or rectum that has spread to other parts of the body. Cetuximab has been shown to slow the growth of tumors in people who have cancer of the colon or rectum. However, it has not been shown to help people who have cancer of the colon or rectum feel better or live longer. Cetuximab is in a class of medications called monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.

Cetuximab comes as a solution (liquid) to be infused (injected slowly) into a vein. Cetuximab is given by a doctor or nurse in a medical office or infusion center. It is usually given once a week.

Side effects of cetuximab fall into one of two groups:

• infusion-related reactions – these may occur during the infusion or for up to an hour afterwards (or rarely up to several hours later)
• other side effects that may occur days or weeks later.
• flu-like symptoms, such as headache, feeling flushed, having a fever, chills, or dizziness
• red, warm and itchy bumps on the skin (like nettle rash)
• a feeling of swelling in the lips, tongue or throat
• breathlessness, wheezing, a cough or sudden difficulty breathing
• a tight chest or chest pain.

Epirubicin is used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. Epirubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.

Epirubicin comes as a solution (liquid) to be injected intravenously (into a vein) by a doctor or nurse in a medical facility along with other chemotherapy medications.

Important Warning:

Epirubicin should be administered only into a vein. However, it may leak into surrounding tissue causing severe irritation or damage. Your doctor or nurse will monitor your administration site for this reaction. If you experience any of the following symptoms, call your doctor immediately: pain, itching, redness, swelling, blisters, or sores in the place where the medication was injected.

Epirubicin may cause serious or life-threatening heart problems at any time during your treatment or months to years after your treatment has ended. Your doctor will order tests before and during your treatment to see if your heart is working well enough for you to safely receive epirubicin. These tests may include an electrocardiogram (ECG; test that records the electrical activity of the heart) and an echocardiogram (test that uses sound waves to measure your heart's ability to pump blood). Your doctor may tell you that you should not receive this medication if the tests show your heart's ability to pump blood has decreased. Tell your doctor if you have or have ever had any type of heart disease or radiation (x-ray) therapy to the chest area. Tell your doctor and pharmacist if you are taking or have ever received certain cancer chemotherapy medications such as daunorubicin (Cerubidine), doxorubicin (Doxil), idarubicin (Idamycin), mitoxantrone (Novantrone), cyclophosphamide (Cytoxan), or trastuzumab (Herceptin). If you experience any of the following symptoms, call your doctor immediately: shortness of breath; difficulty breathing; swelling of the hands, feet, ankles or lower legs; or fast, irregular, or pounding heartbeat.

Epirubicin may increase your risk for developing leukemia (cancer of the white blood cells), especially when it is given in high doses or together with certain other chemotherapy medications.

Epirubicin can cause a severe decrease in the number of blood cells in your bone marrow. This may cause certain symptoms and may increase the risk that you will develop a serious infection or bleeding. If you experience any of the following symptoms, call your doctor immediately: fever, sore throat, ongoing cough and congestion, or other signs of infection; unusual bleeding or bruising.

Epirubicin should be given only under the supervision of a doctor with experience in the use of chemotherapy medications.

Talk to your doctor about the risk(s) of receiving epirubicin.

Fulvestrant is used to treat hormone receptor positive breast cancer (breast cancer that depends on hormones such as estrogen to grow) in women who have experienced menopause (change of life; end of monthly menstrual periods) and whose breast cancer has worsened after they were treated with antiestrogen medications such as tamoxifen (Nolvadex). Fulvestrant is in a class of medications called estrogen receptor antagonists. It works by blocking the action of estrogen on cancer cells. This can slow or stop the growth of some breast tumors that need estrogen to grow.

Fulvestrant comes as a solution (liquid) to be injected into a muscle in the buttocks. Fulvestrant is administered by a doctor or nurse in a medical office. It is usually given once a month. You may receive your entire dose of medication as a single injection, or the dose may be divided into two injections that are given one after another.

A new drug called fulvestrant (Faslodex®) was as effective as another drug, anastrozole (Arimidex®), in postmenopausal women with advanced, previously treated breast cancer, according to two studies published in the August 15, 2002, issue of the Journal of Clinical Oncology.

The women in the studies had been previously treated with the drug tamoxifen, only to have their breast cancer return. Anastrozole belongs to a class of drugs called aromatase inhibitors (AIs). Drugs from this class are the current standard therapy for breast cancer that has recurred or progressed after treatment with tamoxifen.

Leucovorin is a medication that acts the same way in the body as folic acid. Leucovorin is used to reduce the folic-acid-lowering side effects of methotrexate because it is not affected by methotrexate in the same way that folic acid is. Leucovorin is also used in combination with fluorouracil to treat cancer of the colon.

It is also used to treat a condition known as megaloblastic anemia, which is an anemia that can be caused by sprue (a condition resulting from reduced absorption of nutrients from the stomach into the bloodstream) and can occur during pregnancy and infancy.

Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. As well, some forms of this medication may not be used for all of the conditions discussed here. If you have not discussed this with your doctor or are not sure why you are being given this medication, speak to your doctor. Do not stop using this medication without consulting your doctor.

When used in combination with fluorouracil for colon cancer, leucovorin is injected into a vein through a specially prepared site on your skin. In this case, leucovorin is always given under the supervision of a doctor familiar with the use of cancer chemotherapy. It is always given under the supervision of a doctor in a hospital or similar setting with access to sterile equipment for preparation.

The recommended dose for this treatment depends on body size. The treatment is often given once a day for 5 days, just before injection with fluorouracil. This treatment can be repeated every 28 days, depending on response to the therapy.

Etoposide is used alone or in combination with other chemotherapies to treat testicular cancer that has not responded to other treatment and small cell lung cancer. Etoposide works by slowing cancer cell growth. It is also commonly known as VP-16.OTHER This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used to treat certain childhood cancers that have not responded to other treatment, certain types of leukemias, lymphomas, liver cancer, ovarian cancer, esophageal cancer, another type of lung cancer (non-small cell type), and a certain type of prostate cancer.

HOW TO USE: This medication is given by injection into a vein as directed by your doctor, over 30-60 minutes or longer to avoid lowering of blood pressure, which occurs when etoposide is given too quickly. The dosage is based on your medical condition and response to therapy.If you are giving this medication to yourself at home, learn all preparation and usage instructions from your health care professional. Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid. Learn how to store and discard medical supplies safely.Certain types of plastics (e.g., IV bags) have been known to crack or leak when undiluted etoposide is used.

Gemcitabine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug.  Gemcitabine is classified as an antimetabolite.  (For more detail, see "How Gemcitabine Works" below).

What Gemcitabine Is Used For:

Pancreas cancer
Non-small cell lung cancer
Bladder cancer
Soft-tissue sarcoma
Metastatic breast cancer

Note:  If a drug has been approved for one use, physicians sometimes elect to use this same drug for other problems if they believe it might be helpful.

How Gemcitabine Is Given:

Gemcitabine is given by infusion through a vein (intravenously, by IV).
There is no pill form of Gemcitabine.
The amount of Gemcitabine you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer you have.  Your doctor will determine your exact dosage and schedule. 

Side Effects of Gemcitabine:

Important things to remember about the side effects of Gemcitabine:

Most people do not experience all of the side effects listed.
Side effects are often predictable in terms of their onset, duration and severity.
Side effects are almost always reversible and will go away after treatment is complete.
There are many options to help minimize or prevent side effects.
There is no relationship between the presence or severity of side effects and the effectiveness of the medication.

The following side effects are common (occurring in more than 30%) for patients taking Gemcitabine:

Flu-like symptoms(muscle pain, fever, headache, chills, fatigue)
Fever  (within 6-12 hours of first dose)
Fatigue
Nausea (mild)
Vomiting
Poor appetite
Skin rash
Low blood counts.  Your white and red blood cells and platelets may temporarily decrease.  This can put you at increased risk for infection, anemia and/or bleeding.

Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) and other cancers of the blood cells. Imatinib is also used to treat gastrointestinal stromal tumors (GIST; a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body). Imatinib is also used to treat dermatofibrosarcoma protuberans (a tumor that forms under the top layer of skin) when the tumor cannot be removed surgically, has spread to other parts of the body, or has come back after surgery. Imatinib is in a class of medications called protein-tyrosine kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.

Imatinib comes as a tablet to take by mouth. It is usually taken with a meal and a large glass of water once or twice a day. Take imatinib at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take imatinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

If you are unable to swallow imatinib tablets, you may place all of the tablets that you need for one dose into a glass of water or apple juice. Use 50 milliliters (a little less than 2 ounces) of liquid for each 100-mg tablet and 100 milliliters (a little less than 4 ounces) of liquid for each 400-mg tablet. Stir with a spoon until the tablets crumble completely and drink the mixture immediately.

If your doctor has told you to take 800 mg of imatinib, you should take 2 of the 400-mg tablets. Do not take 8 of the 100-mg tablets. The tablet coating contains iron, and you will receive too much iron if you take 8 of the 100-mg tablets.

This medication is used to treat certain types of brain cancer. It is a chemotherapy drug that works by slowing cancer cell growth. In some patients, temozolomide decreases the size of brain tumors.OTHER This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care pro

The capsules should be swallowed whole with plenty of water. They should not be opened or chewed. You should take the capsules at the same time every day on an empty stomach, either an hour before or an hour after food. It's important to make sure you take the capsules exactly as you have been directed by your doctor.

 

Filgrastim is used to decrease the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection), in people who are undergoing bone marrow transplants, and in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood). Filgrastim is also used to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body and then returned to the body following chemotherapy). Filgrastim is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils.

Filgrastim comes as a solution (liquid) to inject under the skin or into a vein. It is usually given once a day, but may be given twice a day when it is used to treat severe chronic neutropenia. The length of your treatment depends on the condition that you have and how well your body responds to the medication. If you are using filgrastim to decrease the risk of infection during chemotherapy, you will receive your first dose of filgrastim at least 24 hours after you receive a dose of chemotherapy, and will continue to receive the medication every day for up to 2 weeks. If you are using filgrastim to decrease the risk of infection during a bone marrow transplant, you will receive the medication at least 24 hours after you receive chemotherapy and at least 24 hours after the bone marrow is infused. If you are using filgrastim to prepare your blood for leukapheresis, you will receive your first dose of filgrastim at least 4 days before the first leukapheresis and will continue to receive the medication until the last leukapheresis. If you are using filgrastim to treat severe chronic neutropenia, you may need to use the medication for a long period of time.

Herceptin is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2+ and has not spread into the lymph nodes. If it has not spread into the lymph nodes, the cancer needs to be estrogen receptor/progesterone receptor (ER/PR)-negative or have one high risk feature.* Herceptin can be used in several different ways:
Trastuzumab is approved to be used alone or with other drugs to treat:

 Adenocarcinoma of the stomach or gastroesophageal junction. It is used for HER2 positive (HER2+) disease that has metastasized (spread to other parts of the body) in patients who have not already been treated for metastatic cancer.

    Breast cancer that is HER2+. It is used in patients whose disease has not gotten better with other chemotherapy.
Trastuzumab usually is administered intravenously with an initial dose of 4 mg per kilogram of body weight followed by a weekly dose of 2 mg per kilogram of body weight.

Ifex® treats certain types of testicular cancer. Mesnex® protects the bladder from damage that may be caused by some cancer medicines.
When This Medicine Should Not Be Used:You should not receive this medicine if you have had an allergic reaction to ifosfamide, mesna, benzyl alcohol, or other medicines that contain sulfur. You should not receive this medicine if you are pregnant. You should not receive this medicine if you have certain severe problems with your bone marrow. How to Use This Medicine: Kit

• Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment.
• You will receive this medicine while you are in a hospital or cancer treatment center. A nurse or other trained health professional will give you this medicine. This medicine is given through a needle placed in one of your veins.
• Drink extra liquids the day before and the day of your treatment, and every day for three days afterward.
• Do not get the medicine on your skin. If it does, wash the area well with soap and water, and tell your caregiver.

If a dose is missed:

• This medicine needs to be given on a fixed schedule. If you miss a dose, call your doctor, home health caregiver, or treatment clinic for instructions.

Leuprolide is a hormone therapy.  It is classified as an "LHRH agonist." For more detail, see "How this drug works" section below).

What this drug is used for:

    Prostate cancer
    Breast, ovarian and endometrial cancer
    Also used in non-cancerous conditions such as endometriosis, infertility, benign prostatic hypertrophy (BPH).

Note:  If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.

How this drug is given:

    As an injection under the skin (subcutaneous, SubQ), or into the muscle (intramuscular, IM).
    May be given as a daily, monthly, or every 3 or 4month injection depending on the formulation and condition being treated.
    Also may be given as a once-a-year implantable device (Viadur(tm)). 

Why is this medication prescribed?

Rituximab is used alone or with other medications to treat certain types of non-Hodgkin's lymphoma (NHL; a type of cancer that begins in a type of white blood cells that normally fights infection). Rituximab is also used with another medication to treat the symptoms of rheumatoid arthritis (RA; a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) in people who have already been treated with a certain type of medication called a tumor necrosis factor (TNF) inhibitor. Rituximab is in a class of medications called biologic antineoplastic agents. It treats NHL by causing the death of blood cells that have multiplied abnormally. It treats rheumatoid arthritis by causing the death of certain blood cells that may cause the immune system to attack the joints.

Rituximab comes as a solution (liquid) to be injected into a vein. Rituximab is administered by a doctor or nurse in a medical office or infusion center. When rituximab is used to treat rheumatoid arthritis, it is usually given as 2 doses spaced 2 weeks apart. When rituximab is used to treat NHL it is either given once a week for 4-8 weeks or on the first day of each chemotherapy cycle. Your dosing schedule will depend on the condition that you have, the other medications you are using, and how well your body responds to treatment.

DTenecteplase is in a group of drugs called tissue plasminogen activators (TPAs). It works by causing the body to over-produce a substance called plasmin to dissolve unwanted blood clots.

Tenecteplase is used to prevent death from a heart attack (acute myocardial infarction).

Tenecteplase may also be used for other purposes not listed in this medication guide.

What are the possible side effects of tenecteplase (TNKase)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Tell your caregivers at once if you have a serious side effect such as:

    Blood in your urine or stools;
    Nosebleed, coughing up blood;
    Bleeding from a recent injury or surgery incision;
    Bleeding around the IV needle;
    Fast, slow, or uneven heart rate; or
    Feeling like you might pass out.

Sorafenib is used to treat advanced renal cell carcinoma (a type of cancer that begins in the kidneys). Sorafenib is also used to treat unresectable hepatocellular carcinoma (a type of liver cancer that cannot be treated with surgery). Sorafenib is in a class of medications called multikinase inhibitors. It works by slowing the spread of cancer cells.
Sorafenib comes as a tablet to take by mouth. It is usually taken twice a day. Sorafenib is taken without food, 1 hour before or 2 hours after a meal. Take sorafenib at around the same times every day.

This medication is used to:

• Treat breast cancer that has spread to other parts of the body in men and women.

• Treat early breast cancer in women who have already been treated with surgery, radiation, and/or chemotherapy.

• Reduce the risk of developing a more serious type of breast cancer in women who have had ductal carcinoma in situ (DCIS; a type of breast cancer that does not spread outside of the milk duct where it forms) and who have been treated with surgery and radiation.

• Reduce the risk of breast cancer in women who are at high risk for the disease due to their age, personal medical history, and family medical history.

Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow.

Tamoxifen is usually taken once or twice a day with or without food. Take tamoxifen at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain anything you do not understand. Take tamoxifen exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow tamoxifen tablets whole; do not split, chew, or crush them. Swallow the tablets with water or any other nonalcoholic drink.

If you are taking tamoxifen to prevent breast cancer, you will probably take it for five years. If you are taking tamoxifen to treat breast cancer, your doctor will decide how long your treatment will last. Do not stop taking tamoxifen without talking to your doctor.

IMPORTANT WARNING:

Tamoxifen may cause cancer of the uterus (womb), strokes, and blood clots in the lungs. These conditions may be serious or fatal. Tell your doctor if you have ever had a blood clot in the lungs or legs, a stroke, or a heart attack. Also tell your doctor if you smoke, if you have high blood pressure or diabetes, if your ability to move around during your waking hours is limited, or if you are taking anticoagulants ('blood thinners') such as warfarin (Coumadin). If you experience any of the following symptoms during or after your treatment, call your doctor immediately: abnormal vaginal bleeding; irregular menstrual periods; changes in vaginal discharge, especially if the discharge becomes bloody, brown, or rusty; pain or pressure in the pelvis (the stomach area below the belly button); leg swelling or tenderness; chest pain; shortness of breath; coughing up blood; sudden weakness, tingling, or numbness in your face, arm, or leg, especially on one side of your body; sudden confusion; difficulty speaking or understanding; sudden difficulty seeing in one or both eyes; sudden difficulty walking; dizziness; loss of balance or coordination; or sudden severe headache.

If you forget to take a dose of tamoxifen, take the missed dose as soon as you remember it, and take your next dose as usual. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

Tamoxifen is also used sometimes to induce ovulation (egg production) in women who do not produce eggs but wish to become pregnant. Tamoxifen is also sometimes used to treat McCune-Albright syndrome (a condition that may cause bone disease, early sexual development, and dark colored spots on the skin in children). Talk to your doctor about the possible risks of using this drug for your condition.

Vinorelbine is a chemotherapy drug usually given to treat breast cancer and non-small cell lung cancer (NSCLC).

Vinorelbine is a colourless fluid. It's also available as 20mg light brown capsules, 30mg pink capsules and 80mg pale yellow capsules. You'll see your hospital doctor regularly while you have this treatment so they can monitor the effects of the chemotherapy.

Vinorelbine may be given into a vein (intravenously) or taken as capsules (orally). The capsules should be swallowed whole with a glass of water and taken exactly as directed by the doctor, nurse or pharmacist.

When given intravenously vinorelbine should only be given to adults and adolescents by drip (infusion) in one of the following ways:

• Through a fine tube (cannula) placed into the vein, usually in the back of the hand 
• Through a fine plastic tube inserted under the skin and into a vein near your collarbone (central line)
• Into a fine tube inserted into a vein in the crook of your arm (PICC line).

The infusion takes around 5-10 minutes.

Children can be given vinorelbine by slow injection into a vein (intravenously) through a cannula or line.

Chemotherapy is usually given as a course of several sessions (cycles) of treatment over a few months. The length of your treatment and the number of cycles you have will depend on the type of cancer you're being treated for. Your nurse or doctor will discuss your treatment plan with you.

Drug Type:

Mitoxantrone is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug.  Mitoxantrone is classified as an "antitumor antibiotic."  (For more detail, see "How Mitoxantrone Works" section below).

What Mitoxantrone Is Used For:

    Advanced prostate cancer not responding to hormone treatment - used in combination with steroids.
    Acute myelogenous leukemia (AML)
    Breast cancer
    Non-Hodgkin's lymphoma
    severe side effects.

The following side effects are common (occurring in greater than 30%) for patients taking Mitoxantrone:

    Low blood counts. Your white and red blood cells and platelets may temporarily decrease. This can put you at increased risk for infection, anemia and/or bleeding.

    Nadir: Meaning low point, nadir is the point in time between chemotherapy cycles in which you experience low blood counts. Onset: 7 - 10 days
    Nadir: 10 -14 days
    Recovery: 21 days

    Nausea and vomiting
    Fever
    Increases in blood tests measuring liver function.  These return to normal once treatment is discontinued.

Erlotinib is used to treat nonsmall cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication and have not gotten better. Erlotinib is also used in combination with another medication (gemcitabine [Gemzar]) to treat pancreatic cancer that has spread to nearby tissues or to other parts of the body. Erlotinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.

Erlotinib comes as a tablet to take by mouth. It is usually taken on an empty stomach once a day, at least 1 hour before or 2 hours after eating a meal or snack. Take erlotinib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take erlotinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Lapatinib is used with capecitabine (Xeloda) to treat a certain type of advanced breast cancer in people who have already been treated with other chemotherapy medications. Lapatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells.

Lapatinib comes as a tablet to take by mouth. It is usually taken once a day, at least 1 hour before or 1 hour after a meal. Take all of the tablets for your daily dose at one time each day; do not divide the tablets to take as separate doses. Take lapatinib at around the same time every day.

Tegafur-uracil is a chemotherapy drug usually given to treat colon and rectal cancer. It's also sometimes called Uftoral.

The capsules should be taken three times a day at regular intervals. They should be swallowed whole and taken either an hour before or an hour after food.

A tablet called calcium folinate  is given with tegafur-uracil. This helps to make tegafur-uracil work more effectively. Both tablets should be taken at the same time.

Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other medication. Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system) who have already been treated with at least one other medication. Bortezomib is in a class of medications called antineoplastic agents. It works by killing cancer cells.

Bortezomib comes as a solution (liquid) to inject into a vein. Bortezomib is given by a doctor or nurse in a medical office or clinic. It is usually given on a rotating schedule that alternates 2 weeks when bortezomib is given twice a week with 10 days when the medication is not given. During the weeks that bortezomib is given, doses will always be at least 72 hours apart. The rotating schedule may be followed for up to eight cycles. After that, your doctor may decide to continue your treatment, but you will receive bortezomib less often.

Idarubicin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "anthracyline antitumor antibiotic
his medication is used to treat:

• Acute myelocytic leukemia

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Idarubicin is a type of antibiotic that is only used in cancer chemotherapy. It slows or stops the growth of cancer cells in your body. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.

Idarubicin has been used to treat other types of leukemia. Talk to your doctor about the possible risks of using this drug for your condition.